Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Thermo Fisher Scientific (NY:TMO)

572.41 +6.43 (+1.14%)
Official Closing Price Updated: 7:00 PM EST, Nov 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Thermo Fisher Scientific

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
30 31 Next >
Thermo Fisher Scientific Reports Third Quarter 2024 Results
From Thermo Fisher Scientific Inc.
Via Business Wire
Earnings Outlook For Thermo Fisher Scientific
 
Via Benzinga
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
Each week, Benzinga’s Stock Whisper Index uses a combination of proprietary data and pattern recognition to showcase five stocks that are just under the surface and deserve attention. 
Via Benzinga
$1000 Invested In This Stock 5 Years Ago Would Be Worth $2,100 Today
 
Via Benzinga
(TMO) - Analyzing Thermo Fisher Scientific's Short Interest
 
Via Benzinga
Novo Nordisk/AstraZeneca's Manufacturing Partner Thermo Fisher Questioned Over Manufacturing Lapses
Thermo Fisher's Greenville facility, one of the largest in the U.S., has faced repeated FDA regulatory violations. Key concerns include contamination prevention and inadequate equipment sterilization... 
Via Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,000 Today
 
Via Benzinga
Is NYSE:TMO suited for quality investing?
Analyzing the Quality Characteristics of THERMO FISHER SCIENTIFIC INC (NYSE:TMO). 
Via Chartmill
Eli Lilly Leads S&P Health Care Stocks With 1,241% Gain. But The Others Aren't Slackers.
Eli Lilly has gained markedly over the past decade. But it's not the only S&P 500 health care stock to notch a bullish gain. 
Via Investor's Business Daily
Topics Stocks
Industry Leader Thermo Fisher's Contract Services Positioned For Growth Amid Popular Demand For GLP-1 Weight Loss Drugs, Analyst Initiates With Long-Term Growth Potential
Stephens initiated coverage on Thermo Fisher Scientific with an Overweight rating and $680 price target. The firm highlights the company's biopharma expansion, M&A strategy, and key growth areas like... 
Via Benzinga
Thermo Fisher Scientific to Hold Earnings Conference Call on Wednesday, October 23, 2024
From Thermo Fisher Scientific Inc.
Via Business Wire
“Nasdaq Stocks Set for Explosive Growth: BNZI, SEEL, PRSO, MSS, HSCS Revamp for Big Potential”
Via AB Newswire
If You Invested $1000 In This Stock 15 Years Ago, You Would Have $13,000 Today
 
Via Benzinga
Spotlight on Thermo Fisher Scientific: Analyzing the Surge in Options Activity
 
Via Benzinga
Looking Into Thermo Fisher Scientific's Recent Short Interest
 
Via Benzinga
Market Movers to Watch: Black Diamond (Nasdaq: BDTX), Peraso Inc. (NASDAQ: PRSO), Kaival Brands (NASDAQ: KAVL) among others w/Key Announcements
Via AB Newswire
Thermo Fisher Scientific Hosts 2024 Investor Day
From Thermo Fisher Scientific Inc.
Via Business Wire
Momentum Investing Gives You An Edge, Until It Doesn’t
Since 2020, momentum investing has generated significantly better returns than other strategies. Such is not surprising, given the massive amounts of stimulus injected into the financial system. 
Via Talk Markets
Thermo Fisher Scientific Stock: A Deep Dive Into Analyst Perspectives (9 Ratings)
 
Via Benzinga
Check Out What Whales Are Doing With TMO
 
Via Benzinga
Time To Invest And Or Trade In Bio-Tech Stocks?
Biotechnology stocks and biotech exchange-traded funds ETFs once played a significant role in growth equity rallies, but today it seems like those days are in the past. Will an interest rate cut help... 
Via Talk Markets
Topics ETFs
Agilent Technologies Thrives From the Forever Chemicals Crackdown
Agilent Technologies Inc. (NYSE: A) is a diversified global leader in the life sciences, diagnostics and applied chemical markets. 
Via MarketBeat
Thermo Fisher Scientific to Present at the Morgan Stanley 22nd Annual Global Healthcare Conference on September 5, 2024
From Thermo Fisher Scientific Inc.
Via Business Wire
$100 Invested In Thermo Fisher Scientific 10 Years Ago Would Be Worth This Much Today
 
Via Benzinga
Thermo Fisher Scientific Stock Sees RS Rating Jump To 81
Thermo Fisher Scientific stock saw a positive improvement to its Relative Strength (RS) Rating on Tuesday, rising from 77 to 81. 
Via Investor's Business Daily
The Defensive Sectors And VIX Have NOT Given The All-Clear Signal
The market has been a rollercoaster lately, with the resilience of defensive sectors and the modest bounce in the technology sector painting an intriguing picture. 
Via Talk Markets
Topics Stocks
Novartis And Viatris Sued Over Unlawful Use Of HeLa Cells Used For Cancer Treatment Drugs
Henrietta Lacks' family sues Novartis and Viatris for profiting from her HeLa cells without consent. The lawsuit seeks profits and aims to prevent further unauthorized use of the cells. 
Via Benzinga
Topics Lawsuit
Here's How Much You Would Have Made Owning Thermo Fisher Scientific Stock In The Last 15 Years
 
Via Benzinga
Healthy Profits: 7 Healthcare Stocks to Build a Lifetime of Wealth
Healthcare stocks offer wealth to investors through a mix of steady performance, growth and income not to be overlooked. 
Via InvestorPlace
3 Stocks With the Most Recent 52-Week Highs
Stocks with 52-week highs could have substantial investment opportunities during the dip in the stock market. 
Via InvestorPlace
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
30 31 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback